Third Generation Vaccine
The issue concerns a third generation carbohydrate-based vaccine developed by participants of the Russian Consortium Conjugated Carbohydrate Vaccines to prevent the most dangerous infections not sensitive to traditional drugs.
The new product was developed by chemists, participants of the Russian Consortium “Conjugated Carbohydrate Vaccines”. It took 15 years to develop the new third generation universal vaccine. Here is what Nickolay Nifantyev, RAS corresponding member says about the new product: “We have developed a vaccine against Staphylococcus aureus. However, it is also active against other types of serious pathogens, including gram-positive and gram-negative bacteria, such as pneumococci, helicobacter, tetracocci – fungi, yeasts, protozoa, tuberculosis pathogens, malaria, etc. These pathogens use the same polysaccharide to form a biofilm for colony protection. These infections are most resistant to traditional and newest antibiotics, which are just ineffective.
Currently the new generation vaccine is assessed in international studies. If positive results are achieved, a new drug for treatment of many serious infections will be available.